Investor Connect – Randy Goldsmith of Rapamycin Holdings

Investor Connect – Randy Goldsmith of Rapamycin Holdings

August 23, 2019 by investor

In this episode, Hall T. Martin conducts an interview with Randy Goldsmith, founder and director of Rapamycin Holdings. Rapamycin Holdings is a San Antonio-based company that is developing and commercializing a patented oral formulation of Rapamycin for the prevention of cancer progression and recurrence. Hall and Randy discuss his background in the industry. They also discuss the FDA process and challenges as well as measuring progress.

 

____________________________________________________

Copyright (c) 2018, Hall Martin and investorconnect.org. All rights reserved.

NOTE: Investor Connect is a program under the Texas Open Angel Network which is a 501(c3) non-profit dedicated to the education around startup funding. Hall Martin is the principal contact, and may be reached at http://www.investorconnect.org/contact.
Music: http://www.bensound.com.

Disclaimer:
Hall T. Martin is the Director of Investor Connect which is 501c3 non-profit dedicated to the education of investors for early stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon as a basis for investment decisions.

Tags: